Navigation Links
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Date:3/3/2008

MONTVALE, N.J., March 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive. In his ruling, Judge Peter G. Sheridan found that the patent at issue was invalid, because it was obvious.

"We are delighted that Judge Sheridan has invalidated the patent on Yasmin," said Bruce L. Downey, Barr's Chairman and CEO. "We are currently reviewing the opinion in the case and evaluating all of our options. Clearly, this is a positive development for the Company and we are evaluating what the potential impact could be on our earnings guidance for 2008."

Yasmin provides an oral contraceptive regimen consisting of 21 active tablets each containing 3 mg of drospirenone and 0.03 mg of ethinyl estradiol and 7 inert tablets. Yasmin is indicated for the prevention of pregnancy in women who elect to use an oral contraceptive. The product had annual sales of approximately $572 million for the twelve months ended December 2007, based on IMS sales data.

Barr filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic Yasmin product with the U.S. Food & Drug Administration (FDA) in January 2005, and received notification of the application's acceptance for filing in February 2005. Following receipt of the notice from the FDA, Barr notified Berlex, the New Drug Application (NDA) holder, and Schering AG, the patent owner. In April 2005, Schering AG and Berlex filed a patent infringement sui
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 On 25-28 July, 2013, ... in Paris - the beautiful city of lights. , ... Medicine is revolutionizing the medical world. Understanding and integrating ... the hallmark of this transformation. Much of the present ... the epidemiologic studies of large cohorts that do not ...
(Date:5/20/2013)... Kitware, a leader in data visualization, ... the exploration of hospital costs across the United ... the recent release of “Medicare Provider Charge Data,” a ... procedures from the Centers for Medicare & Medicaid Services. ... at hospitals across the country has sparked considerable controversy; ...
(Date:5/20/2013)... May 20, 2013 In Early 2013, ... field of biotoxin related illnesses , announced his vision ... able to advance his protocol for treating Chronic Inflammatory ... the third physician to achieve certification in the Shoemaker ... able to practice the Shoemaker Protocol in other parts ...
(Date:5/20/2013)... City, CA (PRWEB) May 20, 2013 ... has announced the appointment of Lisa Baird as Executive ... on July 8, 2013. The WMIS vision ... imaging applications to understand and effectively treat diseases in ... Imaging Society (WMIS) was established in 2011 by integrating ...
Breaking Biology Technology:The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2WMIS Appoints Lisa Baird as Next Executive Director 2
... Prescott, Wis. - The winding roads and hilly terrain ... Mississippi River suggest agriculture or tourism, not high ... to be a wrong turn reveals a surprising destination. , ... soaring eye-level over the bluffs, sits the Phillips Plastics ...
... Corp ., a non-profit development company that helps small businesses, ... technology businesses. , ,MDC said it has closed on loans ... off of Lucigen Corp. , and to BioSystem ... Contest. , ,C5-6 Technologies, which will develop enzymes used to ...
... a series of articles on developing start-up companies in the technology ... business entity. , , Madison, Wis. - ... as to the type of entity to use, you should have ... most people think of first. Income taxes depend upon the type ...
Cached Biology Technology:In western Wisconsin, the innovation economy is growing 2In western Wisconsin, the innovation economy is growing 3Early Stage: Step 6 - Taxes, taxes, taxes! 2Early Stage: Step 6 - Taxes, taxes, taxes! 3Early Stage: Step 6 - Taxes, taxes, taxes! 4
(Date:5/19/2013)... novel study reports that white men and women of ... (hallux valgus) and lesser toe deformities, including hammer or ... to estimate the heritability of foot disorders in humansappear ... published by Wiley on behalf of the American College ... as many as 60% of older adults have foot ...
(Date:5/19/2013)... a strain of electricity-producing bacteria that can grow using ... dioxide as its sole source of carbon. Researchers ... at the 113th General Meeting of the American Society ... current production solely on hydrogen," says Amit Kumar, a ... are part of the Lovley Lab Group at the ...
(Date:5/19/2013)... Scientists at the University of California, Davis have engineered ... need for light. They report their findings today ... for Microbiology. , "In this work, we used synthetic ... on carbon dioxide and light energy for growth) cyanobacterial ... says Jordan McEwen, the lead researcher on the study. ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2
... The tendency toward obesity is directly related to the brain ... according to a new study. Researchers at Tufts University School ... a predisposition to obesity and defective dopamine signaling in the ... 2008 issue of The FASEB Journal . ...
... link between alcohol consumption and increased risk of perennial allergic ... adult women. The study, published in the July ... the risk increased 3% for every additional alcoholic drink per ... increase in risk of seasonal allergic rhinitis according to alcohol ...
... Consuming large quantities of fish loaded with omega-3 fatty acids ... to a study led by the University of Pittsburgh Graduate ... of the Journal of the American College of Cardiology ... study also found that third- and fourth-generation Japanese Americans had ...
Cached Biology News:Obesity predisposition traced to the brain's reward system 2Obesity predisposition traced to the brain's reward system 3Alcohol is associated with risk of perennial allergic rhinitis 2Eating fish may explain very low levels of heart disease in Japan 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
... to histochemically detect specific ... pH in cultured cells ... specific marker is only ... (not found in presenescent/quiescent/immortal ...
Recombinant Mouse LIGHT/TNFSF14...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Biology Products: